Wyeth obtains U.S. approval for Premarin's expanded use
The FDA is allowing Wyeth to market its Premarin cream to treat dyspareunia, or painful sexual intercourse, in postmenopausal women. The approval covers twice-weekly doses of the hormone-replacement drug, which is already sold as a treatment for hot flashes, vaginal dryness and other symptoms of menopause.
Forbes | 11/13
This story published in AANP SmartBrief on 11/14/2008
More from SmartBrief:
FDA approves Salix's gastrointestinal drug Metozolv ODT
Wednesday, September 9, 2009
Get stories like these delivered daily for FREE:
|
AANP SmartBrief
Designed specifically for nurse practitioners and health care professionals like you, AANP SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important health care issues. Learn more |
|